Meridian Life Science offers new antibodies and recombinant antigens for Zika virus, which are suited for the development of rapid assays.
The mosquito-borne Zika virus (ZIKV) is prompting worldwide concern because of its connection to a neurological birth disorder and its rapid spread across the globe. ZIKV is closely related to other mosquito-borne flaviviruses and is primarily transmitted by infected Aedes species mosquitos (A. aegypti and A. albopictus). However spread of the virus through blood transfusion and sexual contact have been reported.
Diagnosis for ZIKV infection include PCR tests to detect viral DNA as well as additional tests to detect ZIKV antibody (IgM) in serum. IgM for ZIKV is typically detectable around 3-5 days after infection, but cross-reactivity with closely related dengue, yellow fever, Japanese encephalitis, and West Nile viruses are possible.
To learn more about Zika Virus CLICK HERE
To request more information CLICK HERE